Verona Pharma Stock (NASDAQ: VRNA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.44M |
Day Range | - - - |
52 Wk Range | 11.39 - 30.73 |
Market Cap | $2.44B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 68 |
Short Interest | 11.58% |
Days to Cover | 10.04 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Verona Pharma (NASDAQ:VRNA) through any online brokerage.
Other companies in Verona Pharma’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA), Longboard Pharmaceuticals (NASDAQ:LBPH) and Axsome Therapeutics (NASDAQ:AXSM).
Verona Pharma has a consensus price target of $35.17.
The stock price for Verona Pharma (NASDAQ: VRNA) is $29.99 last updated September 20, 2024 at 4:39 PM EDT.
There are no upcoming dividends for Verona Pharma.
Verona Pharma’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Verona Pharma.
Verona Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.